Apoptosis induced by PGC-1β in breast cancer cells is mediated by the mTOR pathway

Oncology Reports

Volumn 30, Issue 4, 2013, Pages 1631-1638

  Wang, Libin ^a,b   Liu, Qilun ^b   Li, Fang ^d   Qiu, Jing ^c   Fan, Heng ^b   Ma, Haibin ^b   Zhu, Yongzhao ^b   Wu, Ligang ^b   Han, Xuebo ^b   Yang, Zhihong ^b   Jiang, Haifeng ^b   Wei, Jun ^b   Xia, Haibin ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c QINGDAO MUNICIPAL HOSPITAL   (China)

^d People's Hospital of Ningxia Hui Autonomous Region   (China)

Author keywords

Apoptosis; Mammalian target of rapamycin pathway; MDA MB 231; Peroxisome proliferator activated receptor gamma coactivator 1

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; PROTEIN KINASE B; PROTEIN RAPTOR; PROTEIN RICTOR; PROTEIN S6; SERINE; SHORT HAIRPIN RNA; THREONINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; HEK293 CELLS; HUMANS; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MITOCHONDRIA; MULTIPROTEIN COMPLEXES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84882729732     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2628     Document Type: Article

References (36)

1. Ginsburg OM and Love RR: Breast cancer: a neglected disease for the majority of affected women worldwide. Breast J 17: 289-295, 2011.
2. Lorico A and Rappa G: Phenotypic heterogeneity of breast cancer stem cells. J Oncol 2011: 135039, 2011.
3. Misra Y, Bentley PA, Bond JP, Tighe S, Hunter T and Zhao FQ: Mammary gland morphological and gene expression changes underlying pregnancy protection of breast cancer tumorigenesis. Physiol Genomics 44: 76-88, 2012.
4. Bray F, McCarron P and Parkin DM: The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 6: 229-239, 2004.
5. Perou CM: Molecular stratification of triple-negative breast cancers. Oncologist 16 (Suppl 1): S61-S70, 2011.
6. Liu S and Wicha MS: Targeting breast cancer stem cells. J Clin Oncol 28: 4006-4401, 2010.
7. Tremblay AM and Giguère V: The NR3B subgroup: an ovERRview. Nucl Recept Signal 5: 1-11, 2007.
8. Hartlerode A, Odate S, Shim I, Brown J and Scully R: Cell cycle-dependent induction of homologous recombination by a tightly regulated I-SceI fusion protein. PloS One 6: e16501, 2011.
9. Vezina C, Kudelski A and Sehgal SN: Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot (Tokyo) 28: 721-726, 1975.
10. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK and Puigserver P: mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450: 736-740, 2007
11. Kelly DP and Scarpulla RC: Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18: 357-368, 2004.
12. Spiegelman BM: Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found Symp 287: 60-69, 2007.
13. Arany Z, Lebrasseur N, Morris C, et al: The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab 5: 35-46, 2007.
14. Czubryt MP, McAnally J, Fishman GI and Olson EN: Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100: 1711-1716, 2003.
15. Attia RR, Connnaughton S, Boone LR, et al: Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha). J Biol Chem 285: 2375-2385, 2010.
16. Schieke SM, Phillips D, McCoy JP Jr, et al: The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J Biol Chem 281: 27643-27652, 2006.
17. Ramanathan A and Schreiber SL: Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci USA 106: 22229-22232, 2009.
18. Wu Z, Puigserver P, Andersson U, et al: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-124, 1999.
19. St-Pierre J, Lin J, Krauss S, et al: Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1β) in muscle cells. J Biol Chem 278: 26597-26603, 2003.
20. Hardie DG: Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status. Endocrinology 144: 5179-5183, 2003.
21. Kemp BE, Stapleton D, Campbell DJ, et al: AMP-activated protein kinase, super metabolic regulator. Biochem Soc Trans 31: 162-168, 2003.
22. Willer A: Reduction of the individual cancer risk by physical exercise. Onkologie 26: 283-289, 2003.
23. Gwinn DM, Shackelford DB, Egan DF, et al: AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226, 2008.
24. Kabeya Y, Mizushima N, Ueno T, et al: LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19: 5720-5728, 2000.
25. Hardie DG, Salt IP, Hawley SA and Davies SP: AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J 338: 717-722, 1999.
26. Cao Y and Klionsky DJ: Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res 17: 839-849, 2007.
27. Pattingre S, Espert L, Biard-Piechaczyk M and Codogno P: Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 90: 313-323, 2008.
28. Meirhaeghe A, Crowley V, Lenaghan C, et al: Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J 373: 155-165, 2003.
29. Lin J, Tarr PT, Yang R, et al: PGC-1βeta in the regulation of hepatic glucose and energy metabolism. J Biol Chem 278: 30843-30848, 2003.
30. Finck BN and Kelly DP: PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116: 615-622, 2006.
31. Feige JN and Auwerx J: Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol 17: 292-301, 2007.
32. Peralba JM, DeGraffenried L, Friedrichs W, et al: Pharmacodynamic evaluation of CCI-779, an inhibitor of mTOR, in cancer patients. Clin Cancer Res 9: 2887-2892, 2003.
33. Boulay A, Zumstein-Mecker S, Stephan C, et al: Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells. Cancer Res 64: 252-261, 2004.
34. Basso AD, Mirza A, Liu G, Long BJ, Bishop WR and Kirschmeier P: The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity. J Biol Chem 280: 31101-31108, 2005.
35. Harhaji-Trajkovic L, Vilimanovich U, Kravic-Stevovic T, Bumbasirevic V and Trajkovic V: AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. J Cell Mol Med 13: 3644-3654, 2009.
36. Herrero-Martin G, Høyer-Hansen M, Garcia-Garcia C, et al: TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-treated epithelial cells. EMBO J 28: 677-685, 2009.